Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe AU - Delayed Quote AUD

MedAdvisor Limited (MDR.XA)

0.0970
0.0000
(0.00%)
At close: April 23 at 3:00:29 PM GMT+10
Loading Chart for MDR.XA
  • Previous Close 0.0970
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.5900
  • Volume 21,217
  • Avg. Volume 224,505
  • Market Cap (intraday) --
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0370
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, a vaccination and clinical workflow recording solution; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Melbourne, Australia.

www.medadvisorsolutions.com

--

Full Time Employees

June 30

Fiscal Year Ends

--

Sector

--

Industry

Recent News: MDR.XA

View More

Performance Overview: MDR.XA

Trailing total returns as of 4/27/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

MDR.XA
55.91%
MSCI WORLD (^990100-USD-STRD)
2.41%

1-Year Return

MDR.XA
66.84%
MSCI WORLD (^990100-USD-STRD)
8.50%

3-Year Return

MDR.XA
0.00%
MSCI WORLD (^990100-USD-STRD)
28.89%

5-Year Return

MDR.XA
77.95%
MSCI WORLD (^990100-USD-STRD)
78.91%

Compare To: MDR.XA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MDR.XA

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.51%

  • Return on Assets (ttm)

    -1.35%

  • Return on Equity (ttm)

    -8.34%

  • Revenue (ttm)

    103.66M

  • Net Income Avi to Common (ttm)

    -4.68M

  • Diluted EPS (ttm)

    -0.0370

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.4M

  • Total Debt/Equity (mrq)

    33.53%

  • Levered Free Cash Flow (ttm)

    -10.08M

Research Analysis: MDR.XA

View More

Company Insights: MDR.XA

Research Reports: MDR.XA

View More